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Menopause is a risk factor, in long term, to the increased incidence 
of osteoporosis. Attending to this subject importance, and in order 
to determinate the level of evidence of isoflavones prescription in 
osteoporosis prevention in postmenopausal women, it was consid-
ered pertinent the preparation of this review. We performed a liter-
ature search in databases of National Guideline Clearinghouse, 
Cochrane Library, Canadian Medical Association Practice Guidelines 
InfoBase, DARE, Bandolier, Evidence based Medicine online and 
Pubmed in the last decade studies in English and Portuguese, using 
the terms MeSH: “Isoflavones” and “Bone Density.” For stratified the 
level of evidence and strength of recommendation, the SORT scale of 
the American Academy of Family Physicians was used. Inclusion cri-
teria: PICO (Population: postmenopausal women; Intervention: 
isoflavones; Comparison: other treatments or no one; Outcome: pre-
vention of decreased bone density). 282 articles were founded and 
11 were selected for review, including 4 meta-analyzes, 3 systematic 
reviews and 4 randomized controlled trials. Analyzed studies re-
vealed the existence of controversy in this subject. One meta-analy-
sis and 3 systematic review concluded that isoflavones may prevent 
osteoporosis in postmenopausal women, however this effect will 
depend on factors such as the dose, the treatment duration and the 
time since menopause. It is also necessary to consider possible inter-
actions between isoflavones and anti-osteoporotic drugs, so it is 
premature to recommend the prescription of these supplements. 
A meta-analysis was inconclusive. 4 clinical trials and 2 meta-ana-
lyzes concluded there is no benefit in supplementation with isofla-
vones in the prevention of osteoporosis. With this review we 
concluded that isoflavones may have some effect in preventing oste-
oporosis but there is insufficient evidence to justify their prescrip-
tion for this purpose (level of evidence 1, grade A of recommendation).
P07. EARLY MENOPAUSE AND DECLINE OF BONE 
MINERAL DENSITY – A CLINICAL REPORT
Ângela Lee Chin, Ana Filipa Vicente, Olena Berezovska Lourenço
Medicina Geral e Familiar.
Osteoporosis is the most common bone disease characterized by 
increased loss of bone mass and deterioration of its microstructure, 
increasing the risk of fracture. There are multiple risk factors for its 
development, particularly affecting women after menopause. We 
report the case of 35 years old woman that came to our general prac-
tice consultation in January 2016, with complaints of intense back 
pain and low back pain without irradiation, with months of evolu-
tion, without history of previous trauma and pain with mechanical 
characteristics. From her case history stands out: early menopause 
when she was 21, secondary to chemotherapy and radiation therapy 
due to invasive ductal carcinoma of the breast in 2001; Acute lym-
phoblastic leukemia in 2006 followed by new chemotherapy, radia-
tion therapy, long term corticosteroid therapy and bone marrow 
transplant in 2007; bilateral hip prosthesis after aseptic necrosis in 
2008, with dysmetria of members. She remains being followed by 
Oncology. Bone densitometry in 2015 compatible with osteopenia, 
having as chronic medication calcium and cholecalciferol. On the 
objective examination, is observed limbing, without pain on palpa-
tion of the spinous process of vertebra or others changes. We pre-
scribed topical anti-inf lammatory, oral muscle relaxant and 
analgesic therapy. The radiography of column and bilateral hip ex-
cluded osteoporotic fractures. The osteoarticular complaints in this 
context could be attributed to an osteoporotic fracture, and bone 
metastasis, but this probability is reduced by frequent follow-up in 
oncology. Considering to early menopause and osteopenia, it is indi-
cated supplementation with calcium and vitamin D. Furthermore, 
hormone replacement therapy is contra-indicated in this patient. 
The family doctor, with his holistic approach and continuity of care, 
is essential in the early detection of the disease, taking into account 
the risk factors of this patient, and also in reinforcement of the im-
plementation of long-term preventive measures (pharmacological 
and non-pharmacological).
P08. EPIDEMIOLOGY OF LOWER LIMB FRACTURES 
IN UKRAINIAN POPULATION
Nataliia Grygorieva, Volodymyr Vayda, Roman Vlasenko, 
Ostap Zubach
Institute of Gerontology named D.F. Chebotarev NAMS Ukraine.
Introduction: Fractures are a considerable public health burden 
but information on their epidemiology in Ukraine is limited.
Objectives: The aim of the study was to establish the incidence of 
lower limb fractures in Ukrainian population.
Methods: We identified 665 subjects from 76,765 citizens, living 
in Vinnitsa region, who had a first time (incident) diagnosis of lower 
limb fractures recorded in the regional Hospital database from 
1.01.2011 to 31.12.2011.
Results: Frequency the lower limb fractures of was 42.4% from 
the total fractures in all patients and 44.4% from the total fractures 
in patient aged 50 years and older. The most common anatomic site 
of lower limb fractures was the tibia and/or fibula (48.9% of all inci-
dent lower limb fractures), followed by the hip (29.5%), and the tar-
sal/metatarsal bones (21.6%). Incidence of fracture in patient 50 years 
and old was 519.8 per 10,000 patient for lower limb fractures, 212.3 
per 10,000 patient for tibia and/or fibula fractures and 226.9 per 
10,000 patient for hip fracture, Lower limb fractures were more com-
mon among males than among females in the younger age groups 
(up to 39 years old). Among subjects 50 years and older the incidence 
of lower limb fractures was higher in women than in men, and the 
difference increased with increasing age. Incidence of the tibia and/
or fibula fractures was 340.7 per 10,000 patient in the age group 60-
69 years old, 44.9 per 10,000 patient in age group 70-79 years old, 
and 102.4 per 10,000 patient in age group 80-89 years old.
Conclusions: Our study provided the new information about the 
epidemiology of lower limb fractures in Ukrainian population ac-
cording the age. This information is important for planning of the 
prevention and treatment strategy in patients of different ages.
P09. FEMORAL FRACTURE, REALITY IN A FAMILY HEALTH 
UNIT
Ana Sara Rodrigues, Rita Gomes
Medicina Geral e Familiar.
Introduction: Osteoporosis is characterized by low bone mass 
and deterioration of bone microarchitecture, weakening the bone 
and increasing the risk of fracture. Post-menopausal women and el-
derly men and women are the groups which are at greater risk of 
suffering from osteoporotic fractures.
Objectives: To assess the prevalence of hip fracture at the Family 
Health Unit and verify the indication for bone osteodensitometria.
Methods: Cross-sectional study. We analyzed all patients coded 
with the diagnosis of hip fracture (L75 coding) during the year of 
2015. The data were obtained from the MIM@UF program.
Results: In the year of 2015, a total of 13 patients were coded with 
femoral fracture, with a prevalence of 0.13%. Regarding the sample 
of users, 4 were males and 9 of the patients were female. Patients 
were between 57 and 105 years old, with an average age of 83.7 years. 
Of the total patients evaluated, none previously had a bone oste-
odensitometria prescription or pharmacological treatment with 
anti- resorptive therapy.
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Conclusions: The goal of the approach and treatment of osteopo-
rosis is to reduce the number of osteoporotic fractures. Of the 13 pa-
tients observed, 12 had clearly indication for a osteodensitometria, 
according to the age criteria. This review highlights the need for a 
correct approach to osteoporosis, which measures may prevent os-
teoporotic fractures and consequently diminished quality of life.
P10. OSTEOPENIA SYNDROME IN CHILDREN 
AT PRESENT TIME
Tatiana Frolova, Olga Okhapkina, Iryna Siniaieva, 
Viktoriya Lazurenko, Olga Shevchenko
Kharkiv National Medical University, Ukraine.
Introduction: Pathology of the musculoskeletal system takes one 
of the leading places in the structure of child morbidity in Ukraine.
Objectives: Revealing of peculiarities in the formation of osteo-
poenia syndrome in children and adolescents at the present stage.
Methods: Monitoring of the structural and functional state of the 
bone tissue among 4,200 children students aged 9-18 years of Kharkiv 
region was conducted during 2005-2015. The study of the bone tis-
sue’s state was performed on the ultrasound densitometer “Sonost. 
2000” and on the base of biochemical markers of bone remodeling.
Results: Over the last 10 years the negative dynamic in the state 
of bone tissue was observed. The incidence of osteopenia (OP) among 
students was increased in 1.4 times (from (29.5 ± 3.1)% in 2005 to 
(41.2 ± 3.6)% in 2015). It was found the increase of moderate OP (from 
(36.7 ± 2.8)% in 2005 to (46.1 ± 4.1)% in 2015) and decrease of mild OP 
((43.3 ± 5.1)% and (32.8 ± 3.8)%, respectively), while the prevalence of 
3-rd degree remains at the same level ((20.0 ± 2.5)% and (21.1 ± 2.5)%, 
respectively). The OP was increased in 2 times in puberty ((18.2 ± 
2.0)% and (35.6 ± 4.7)%, respectively, in 2005 and 2015. 68% of stu-
dents have primary OP of 2-nd degree. Hypodynamia (r = 0.92), eat-
ing disorders with excessive consumption of sweet carbonated 
beverages, snacks and fast food products (r = 0.88) and having bad 
habits (r = 0.86) are the significant medical and social risk factors of 
OP in adolescents. Regarding biochemical markers, the most influ-
ential are the increase of daily oxyproline excretion (r = 0.84) and 
reduction of I fraction of glucosamin glucan sulfates (r = 0.85).
Conclusions: Detection of risk factors allows us to predict disor-
ders of structural and functional state of bone tissue and to conduct 
OP prophylaxis.
P11. ADVERSE EFFECTS OF BISPHOSPHONATES 
IN THE TREATMENT OF OSTEOPOROSIS. A CLINICAL CASE
Juliana Caçoilo
Medicina Geral e Familiar.
Introduction: Osteoporosis is a high prevalence disease and it is 
expected to increase its number of cases in the upcoming decades 
associated with the aging of the world population. It is often con-
nected with increased morbidity and mortality and reduced quality 
of life, as well. Therefore, its treatment and prevention are extremely 
important. Pharmacological treatment of osteoporosis may include 
the use of bisphosphonates. However, the frequent occurrence of ad-
verse effects and drug intolerance may decrease therapy adherence, 
making it difficult to control the disease. We present a case of a female 
patient with onset of ocular symptoms after starting alendronate.
Objectives: Review recent evidence of adverse effects associated 
with the use of bisphosphonates in the treatment of osteoporosis.
Methods: Classical Review. Research published articles in 
PubMed database using the MeSH terms “bisphosphonates”, “ad-
verse effects”.
Results: The orally administered bisphosphonates are usually 
well tolerated, but often associated with upper gastrointestinal 
symptoms such as epigastric pain, dyspepsia, nausea and vomiting. 
There were also reports of osteonecrosis of the jaw, atrial fibrillation, 
atypical fractures of the femur and ocular events.
Conclusions: Bisphosphonates are an important feature in the 
treatment of osteoporosis, reducing the risk of vertebral and non-
-vertebral fracture. The safety and tolerability of bisphosphonates is 
sustained and serious adverse reactions are rare. However, the pos-
sible effects should be known when prescribing this drugs, taking 
into account the characteristics and personal history of each patient.
P12. TRÊS CASOS DE MANIFESTAÇÕES REUMÁTICAS 
NA HEMOCROMATOSE
Joana Borges, Susana Fernandes, Cândida Silva, Rui Leitão, 
Eugénia Simões, Augusto Faustino
Instituto Português de Reumatologia.
Introdução: A hemocromatose é uma doença hereditária do me-
tabolismo do ferro, frequentemente associada a mutações no gene 
HFE (C282Y/H63D, homozigotia/heterozigotia composta), com envol-
vimento músculo-esquelético frequente (até 64%) mas variável, sa-
lientando-se a associação com osteopénia.
Casos clínicos: Caso 1: M.F.L.M., feminino, 55 anos, pós-menopau-
sa. Avaliada por poliartralgia inflamatória. Velocidade de sedimenta-
ção (VS), proteína C reativa (PCR), anticorpos antinucleares (ANA), 
anti-péptido citrulinado, HLA-B27 negativos, fator reumatoide (FR) 
borderline. Densitometria óssea (DXA): T-score rádio total -3,13, fémur 
total -0,61 e L2-L4 -0,44. Foi medicada com celecoxibe (400 mg/dia), 
deflazacorte (6 mg/dia), alendronato e suplementação de vitamina D 
por hipovitaminose D. Apresentava elevação das enzimas hepáticas e 
de ferritina (máximo: 421 g/L), siderémia e hemoglobina normais. O 
estudo genético documentou heterozigotia composta H63D/C282Y. 
Caso 2: E.S.B., masculino, 59 anos. Quadro de perda ponderal (≈10 Kg) 
há cerca de 3 anos, mantendo elevação dos parâmetros inflamatórios. 
Avaliado por poliartralgia com episódios de tumefação das articula-
ções das mãos, iniciando meloxicam e deflazacorte por períodos. Ana-
liticamente: VS e PCR elevadas; ferritina 559 g/L, sideremia normal; 
ANA, anti-dsDNA, anti-SSA/SSB, anti-mitocôndrias, FR e HLA-B27 
negativos. Radiografia das mãos com rizartrose bilateral e aspetos de-
generativos de interfalângicas distais. O estudo genético revelou hete-
rozigotia composta para hemocromatose. Caso 3: J.S.A, masculino, 80 
anos. Avaliado por podalgia mecânica, com radiografia e tomografia 
dos pés compatíveis com artrose das tíbio-társicas e tarso-metatársi-
cas e aspetos de diminuição da trabeculação óssea, predominante-
mente juxta-articulares; DXA com T score -2,1 (colo do fémur). 
Analiticamente: VS, PCR e enzimologia hepática sem alterações, FR 
negativos, ANA 1:320, ferritina 729,8 g/L, sideremia normal e vitami-
na D 8 g/L, iniciando suplementação de vitamina D. O estudo genéti-
co documentou homozigotia para a mutação C282Y do gene HFE.
Discussão: Os casos ilustram a diversidade das manifestações 
reumáticas em doentes com hemocromatose. Todos cursaram com 
poliartralgia, com localização e ritmo variáveis, verificando-se perda 
de massa óssea em dois casos.
P13. VITAMIN D BURNOUT
Janine Correia, Juliana Caçoilo, Tânia Sequeira, Inês Calvinho, 
Carlos Bento
Medicina Geral e Familiar.
Introduction: Vitamin D deficiency is a common problem, un-
derdiagnosed and undertreated between Portuguese population. It 
